MCM
MXCT icon

MAI Capital Management’s MaxCyte MXCT Stock Holding History

MAI Capital Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170 Buy
+242
New +$226 ﹤0.01% 4654

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

MAI Capital Management's MXCT Position: Q1 2026 in Review

MAI Capital Management opened a new position in MaxCyte (MXCT) in Q1 2026: 242 shares worth $170. The stake represents ﹤0.01% of the portfolio and ranks #4654 among its holdings.

130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • MAI Capital Management held 242 shares of MaxCyte worth $170 as of Q1 2026.
  • MaxCyte was a new MAI Capital Management position in Q1 2026.
  • MaxCyte made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4654 holding.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.